Oral Session 1-5A AML: AlloHSCT

[OS1-5A-1] Hematopoietic cell transplantation for children with acute megakaryoblastic leukemia

Asahito Hama¹, Takashi Taga², Daisuke Tomizawa³, Hideki Muramatsu¹, Dai-Ichiro Hasegawa⁴, Souichi Adachi⁵, Koji Kato⁶, Maiko Noguchi⁷, Masami Inoue⁸, Keiko Okada⁹, Katsuyoshi Koh¹⁰, Yoshiko Atsuta¹¹, Hiroyuki Ishida¹² (1.Nagoya University Graduate School of Medicine, Nagoya, Japan, 2.Department of Pediatrics, Shiga Medical University, Otsu, Japan, 3.Division of Leukemia, National Center for Child Health, Tokyo, Japan, 4.Department of Hematology/Oncology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan, 5.Department of Human Health Science, Kyoto University, Kyoto, Japan, 6.Department of Pediatrics, Red Cross Nagoya First Hospital, Nagoya, Japan, 7.Department of Pediatrics, National Kyushu Cancer Center, Fukuoka, Japan, 8.Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Izumi, Japan, 9.Department of Pediatric Hematology/Oncology, Osaka City General Hospital, Osaka, Japan, 10.Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan, 11.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 12.Department of Pediatrics, Kyoto City Hospital, Kyoto, Japan)